SAR — Sareum Holdings Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Capital Access Window
AIM - AIM Notice - 08/09/2026
Exercise of Warrants
AIM - AIM Notice - 24/08/2026
Exercise of Warrants
AIM - AIM Notice - 13/08/2026
Exercise of Warrants
Exercise of Warrants
UK's Sareum posts half-year loss as R&D spending continues
Brief: Sareum H1 Pretax Profit GBP -1.852 Million
Half-Year Report for Six Months Ended 31 Dec 2025
Notice of Results and Investor Presentation
Brief: Sareum Holdings Restarts Phase 2-Enabling Toxicology Programme For SDC-1801
Brief: Sareum Holdings Continues To Review Optimum Level Of Staffing, Including Chief Medical Officer And CEO
Annual General Meeting Statement
Notice of AGM, Annual Report and Accounts
Preliminary Results for Year Ended 30 June 2025
Brief: Sareum Holdings Announces Discontinuation Of Toxicology Study For SDC-1801
Update on toxicology study for SDC-1801